摘要
目的和方法:应用基因工程技术,将EGFcDNA克隆到pLY5/IL2-PE40载体的EcoRⅠ、SmaⅠ位点之间IL2基因位置上,再将重组融合基因亚克隆到表达载体pBV220的EcoRⅠ、PstⅠ位点上,以探索EGF-PE40融合基因在大肠杆菌DH5a中的进行表达及其生理功能。结果:SDS-聚丙烯酰胺凝胶电泳和Westernblot表明:EGF-PE40融合蛋白获得表达,并且具有EGF和PE40的免疫学活性。
Abstract AIM and METHOD:In order to study the expression of fusion protein EGF-PE40 in E. coli DH 5a and the function, human EGF cDNA was cloned into the vector pLY5/IL2-PE40 at the EcoRⅠ and SamⅠ sites, where the IL2 gene was substituted. Subsequently recombined EGF-PE40 gene was subcloned into the expression Vector pBV220 of the EcoRⅠ and PstⅠ sites. RESULTS: A recombinant fusion protein was expressed successfully in high effect in E. coli confirmed by SDS-PAGE and Western blot. CONCLUSION:These results provide an important basis for EGF-PE40 protein and biological activities of the targetting tumor therapy. MeSH Eqidermal growth; Recombinant fusion proteins;
出处
《中国病理生理杂志》
CAS
CSCD
北大核心
1998年第6期603-607,共5页
Chinese Journal of Pathophysiology
基金
国家自然科学基金
湖南省科委科研基金